Advair's throne is slowly eroding. With stepped-up competition from rival lung drugs--including AstraZeneca's ($AZN) Symbicort--GlaxoSmithKline's ($GSK) top-selling ...
BURLINGTON, Mass.--(BUSINESS WIRE)-- Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that patient share of ...
The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk that ...
LargePharma_SymbicortAstraZeneca’s Symbicort, the second-to-market ICS/LABA combo behind GlaxoSmithKline’s Advair, faced an uphill battle on its launch in June 2007, squaring off against a firmly ...
WASHINGTON — Two federal drug officials have concluded that asthma patients risk death if they continue to use four hugely popular asthma drugs: Advair, Symbicort, Serevent and Foradil. But the ...
On November 18, 2005, FDA alerted health care professionals and patients that several long-acting bronchodilator medicines have been associated with possible increased risk of worsening wheezing ...
GSK’s partnership with Theravance has yielded a pair of promising COPD treatments -- but will they be enough to protect it from Advair’s patent expirations? GSK's COPD drug candidate, Anoro Ellipta, ...
Government health advisers Thursday called for restrictions on some long-acting asthma drugs, but spared Advair, a top-selling medication used by millions of patients. Outside experts advising the ...
GlaxoSmithKline is shifting its sales force strategy for therapy Advair to stress treatment for chronic obstructive pulmonary disease (COPD), a new report stated. Advair, a long-acting beta2 agonist ...
WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...
Government health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication. Outside experts advising the Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback